Polskie Archiwum Medycyny Wewnetrznej
Tomecki R, Gerke W.
PMID: 7854963
Pol Arch Med Wewn. 1994 Oct;92(4):347-52.
No abstract available.
Cite
Tomecki R, Gerke W. Badania przesiewowe w nowotworach jelita grubego--dziś i jutro. [Screening for colorectal neoplasms--today and tomorrow]. Pol Arch Med Wewn. 1994;92(4):347-52
Tomecki, R., & Gerke, W. (1994). Badania przesiewowe w nowotworach jelita grubego--dziś i jutro. [Screening for colorectal neoplasms--today and tomorrow]. Polskie Archiwum Medycyny Wewnetrznej, 92(4), 347-52.
Tomecki, R, and Gerke, W. "Badania przesiewowe w nowotworach jelita grubego--dziś i jutro." [Screening for colorectal neoplasms--today and tomorrow]. Polskie Archiwum Medycyny Wewnetrznej vol. 92,4 (1994): 347-52.
Tomecki R, Gerke W. Badania przesiewowe w nowotworach jelita grubego--dziś i jutro. [Screening for colorectal neoplasms--today and tomorrow]. Pol Arch Med Wewn. 1994 Oct;92(4):347-52. Polish. PMID: 7854963.
Copy
Download .nbib
Retina (Philadelphia, Pa.)
Recchia FM, Capone A.
PMID: 15097891
Retina. 2004 Apr;24(2):283-92. doi: 10.1097/00006982-200404000-00015.
No abstract available.
Cite
Recchia FM, Capone A. Contemporary understanding and management of retinopathy of prematurity. Retina. 2004;24(2):283-92doi: 10.1097/00006982-200404000-00015.
Recchia, F. M., & Capone, A. (2004). Contemporary understanding and management of retinopathy of prematurity. Retina (Philadelphia, Pa.), 24(2), 283-92. https://doi.org/10.1097/00006982-200404000-00015
Recchia, Franco M, and Capone, Antonio. "Contemporary understanding and management of retinopathy of prematurity." Retina (Philadelphia, Pa.) vol. 24,2 (2004): 283-92. doi: https://doi.org/10.1097/00006982-200404000-00015
Recchia FM, Capone A. Contemporary understanding and management of retinopathy of prematurity. Retina. 2004 Apr;24(2):283-92. doi: 10.1097/00006982-200404000-00015. PMID: 15097891.
Copy
Download .nbib
Methods in molecular biology (Clifton, N.J.)
Stracci F.
PMID: 19109777
Methods Mol Biol. 2009;471:107-36. doi: 10.1007/978-1-59745-416-2_6.
Screening should allow for the anticipation of cancer diagnosis at an earlier stage, when curative treatment is possible. Screening for cervical, large bowel, and breast cancer were shown to be effective in reducing mortality. The wide acceptance of the...
Cite
Stracci F. Cancer screenings, diagnostic technology evolution, and cancer control. Methods Mol Biol. 2009;471:107-36doi: 10.1007/978-1-59745-416-2_6.
Stracci, F. (2009). Cancer screenings, diagnostic technology evolution, and cancer control. Methods in molecular biology (Clifton, N.J.), 471107-36. https://doi.org/10.1007/978-1-59745-416-2_6
Stracci, Fabrizio. "Cancer screenings, diagnostic technology evolution, and cancer control." Methods in molecular biology (Clifton, N.J.) vol. 471 (2009): 107-36. doi: https://doi.org/10.1007/978-1-59745-416-2_6
Stracci F. Cancer screenings, diagnostic technology evolution, and cancer control. Methods Mol Biol. 2009;471:107-36. doi: 10.1007/978-1-59745-416-2_6. PMID: 19109777.
Copy
Download .nbib
Collegium antropologicum
Primic-Zakelj M, Repse-Fokter A.
PMID: 17600934
Coll Antropol. 2007 Apr;31:23-6.
In Slovenia, opportunistic screening was introduced in regular gynaecological practice in 1960. The proportion of population screened was unknown, as well as there were no standards for quality assurance and control. Despite great number of smears read, there were...
Cite
Primic-Zakelj M, Repse-Fokter A. Cervical cancer screening: A Slovenian experience. Coll Antropol. 2007;31:23-6
Primic-Zakelj, M., & Repse-Fokter, A. (2007). Cervical cancer screening: A Slovenian experience. Collegium antropologicum, 3123-6.
Primic-Zakelj, Maja, and Repse-Fokter, Alenka. "Cervical cancer screening: A Slovenian experience." Collegium antropologicum vol. 31 (2007): 23-6.
Primic-Zakelj M, Repse-Fokter A. Cervical cancer screening: A Slovenian experience. Coll Antropol. 2007 Apr;31:23-6. PMID: 17600934.
Copy
Download .nbib
BMJ (Clinical research ed.)
Gulland A.
PMID: 27913375
BMJ. 2016 Dec 02;355:i6518. doi: 10.1136/bmj.i6518.
No abstract available.
Cite
Gulland A. Eleven million people are in line for HIV tests through routine NHS contact. BMJ. 2016;355:i6518doi: 10.1136/bmj.i6518.
Gulland, A. (2016). Eleven million people are in line for HIV tests through routine NHS contact. BMJ (Clinical research ed.), 355i6518. https://doi.org/10.1136/bmj.i6518
Gulland, Anne. "Eleven million people are in line for HIV tests through routine NHS contact." BMJ (Clinical research ed.) vol. 355 (2016): i6518. doi: https://doi.org/10.1136/bmj.i6518
Gulland A. Eleven million people are in line for HIV tests through routine NHS contact. BMJ. 2016 Dec 02;355:i6518. doi: 10.1136/bmj.i6518. PMID: 27913375.
Copy
Download .nbib
Lancet (London, England)
[No authors listed]
PMID: 1975338
Lancet. 1990 Aug 11;336(8711):346-8.
No abstract available.
Cite
Antenatal screening for toxoplasmosis in the UK. Lancet. 1990;336(8711):346-8
(1990). Antenatal screening for toxoplasmosis in the UK. Lancet (London, England), 336(8711), 346-8.
"Antenatal screening for toxoplasmosis in the UK." Lancet (London, England) vol. 336,8711 (1990): 346-8.
Antenatal screening for toxoplasmosis in the UK. Lancet. 1990 Aug 11;336(8711):346-8. PMID: 1975338.
Copy
Download .nbib
Ugeskrift for laeger
Kronborg O.
PMID: 2916263
Ugeskr Laeger. 1989 Jan 23;151(4):260-3.
No abstract available.
Cite
Kronborg O. Screening for kraeft, fordele og ulemper. [Screening of cancer, advantages and disadvantages]. Ugeskr Laeger. 1989;151(4):260-3
Kronborg, O. (1989). Screening for kraeft, fordele og ulemper. [Screening of cancer, advantages and disadvantages]. Ugeskrift for laeger, 151(4), 260-3.
Kronborg, O. "Screening for kraeft, fordele og ulemper." [Screening of cancer, advantages and disadvantages]. Ugeskrift for laeger vol. 151,4 (1989): 260-3.
Kronborg O. Screening for kraeft, fordele og ulemper. [Screening of cancer, advantages and disadvantages]. Ugeskr Laeger. 1989 Jan 23;151(4):260-3. Danish. PMID: 2916263.
Copy
Download .nbib
Arztliche Jugendkunde
Cross A.
PMID: 3223447
Arztl Jugendkd. 1988;79(3):149-57.
No abstract available.
Cite
Cross A. Health screening in schools. The U.S. experience. Arztl Jugendkd. 1988;79(3):149-57
Cross, A. (1988). Health screening in schools. The U.S. experience. Arztliche Jugendkunde, 79(3), 149-57.
Cross, A. "Health screening in schools. The U.S. experience." Arztliche Jugendkunde vol. 79,3 (1988): 149-57.
Cross A. Health screening in schools. The U.S. experience. Arztl Jugendkd. 1988;79(3):149-57. PMID: 3223447.
Copy
Download .nbib
The oncologist
McMahon PM, Gazelle SG.
PMID: 18649407
Oncologist. 2008 Jun;13(6):733. doi: 10.1634/theoncologist.2008-0116.
No abstract available.
Cite
McMahon PM, Gazelle SG. Response to "comentary: lung cancer screening--progress or peril. Oncologist. 2008;13(6):733doi: 10.1634/theoncologist.2008-0116.
McMahon, P. M., & Gazelle, S. G. (2008). Response to "comentary: lung cancer screening--progress or peril. The oncologist, 13(6), 733. https://doi.org/10.1634/theoncologist.2008-0116
McMahon, Pamela M, and Gazelle, Scott G. "Response to "comentary: lung cancer screening--progress or peril." The oncologist vol. 13,6 (2008): 733. doi: https://doi.org/10.1634/theoncologist.2008-0116
McMahon PM, Gazelle SG. Response to "comentary: lung cancer screening--progress or peril. Oncologist. 2008 Jun;13(6):733. doi: 10.1634/theoncologist.2008-0116. PMID: 18649407.
Copy
Download .nbib
Journal of medical screening
Wald NJ, Morris JK.
PMID: 8861041
J Med Screen. 1996;3(1):1. doi: 10.1177/096914139600300101.
No abstract available.
Cite
Wald NJ, Morris JK. What is case-finding?. J Med Screen. 1996;3(1):1doi: 10.1177/096914139600300101.
Wald, N. J., & Morris, J. K. (1996). What is case-finding?. Journal of medical screening, 3(1), 1. https://doi.org/10.1177/096914139600300101
Wald, N J, and Morris, J K. "What is case-finding?." Journal of medical screening vol. 3,1 (1996): 1. doi: https://doi.org/10.1177/096914139600300101
Wald NJ, Morris JK. What is case-finding?. J Med Screen. 1996;3(1):1. doi: 10.1177/096914139600300101. PMID: 8861041.
Copy
Download .nbib
The American review of respiratory disease
Bailar JC.
PMID: 6486553
Am Rev Respir Dis. 1984 Oct;130(4):541-2. doi: 10.1164/arrd.1984.130.4.541.
No abstract available.
Cite
Bailar JC. Screening for lung cancer--where are we now?. Am Rev Respir Dis. 1984;130(4):541-2doi: 10.1164/arrd.1984.130.4.541.
Bailar, J. C. (1984). Screening for lung cancer--where are we now?. The American review of respiratory disease, 130(4), 541-2. https://doi.org/10.1164/arrd.1984.130.4.541
Bailar, J C. "Screening for lung cancer--where are we now?." The American review of respiratory disease vol. 130,4 (1984): 541-2. doi: https://doi.org/10.1164/arrd.1984.130.4.541
Bailar JC. Screening for lung cancer--where are we now?. Am Rev Respir Dis. 1984 Oct;130(4):541-2. doi: 10.1164/arrd.1984.130.4.541. PMID: 6486553.
Copy
Download .nbib
Epidemiologia e prevenzione
Oleari F.
PMID: 21268768
Epidemiol Prev. 2010 Sep-Dec;34(5):3.
No abstract available.
Cite
Oleari F. Foreword. The progressive expansion of screening programmes. Epidemiol Prev. 2010;34(5):3
Oleari, F. (2010). Foreword. The progressive expansion of screening programmes. Epidemiologia e prevenzione, 34(5), 3.
Oleari, Fabrizio. "Foreword. The progressive expansion of screening programmes." Epidemiologia e prevenzione vol. 34,5 (2010): 3.
Oleari F. Foreword. The progressive expansion of screening programmes. Epidemiol Prev. 2010 Sep-Dec;34(5):3. PMID: 21268768.
Copy
Download .nbib
